Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

B Hallberg, RH Palmer - Nature Reviews Cancer, 2013 - nature.com
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many
cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer …

[PDF][PDF] Epigenetics meets endocrinology

X Zhang, SM Ho - Journal of molecular endocrinology, 2011 - jme.bioscientifica.com
Although genetics determines endocrine phenotypes, it cannot fully explain the great
variability and reversibility of the system in response to environmental changes. Evidence …

[HTML][HTML] Force sensing by mechanical extension of the Src family kinase substrate p130Cas

Y Sawada, M Tamada, BJ Dubin-Thaler… - Cell, 2006 - cell.com
How physical force is sensed by cells and transduced into cellular signaling pathways is
poorly understood. Previously, we showed that tyrosine phosphorylation of p130Cas (Cas) …

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy

TR Webb, J Slavish, RE George, AT Look… - Expert review of …, 2009 - Taylor & Francis
Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase in the insulin receptor
superfamily, was initially identified in constitutively activated oncogenic fusion forms–the …

[HTML][HTML] Anaplastic lymphoma kinase in human cancer

A Barreca, E Lasorsa, L Riera… - Journal of …, 2011 - jme.bioscientifica.com
Although genetics determines endocrine phenotypes, it cannot fully explain the great
variability and reversibility of the system in response to environmental changes. Evidence …

Teaching an old dogma new tricks: twenty years of Shc adaptor signalling

MKB Wills, N Jones - Biochemical Journal, 2012 - portlandpress.com
Shc (Src homology and collagen homology) proteins are considered prototypical signalling
adaptors in mammalian cells. Consisting of four unique members, ShcA, B, C and D, and …

[HTML][HTML] Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway

Y Liu, H Zhuang, F Cao, J Li, Y Guo, J Zhang… - Cell Death & …, 2021 - nature.com
Hepatocellular carcinoma (HCC) is one of the most common cancers with an insidious
onset, strong invasiveness, insensitivity to chemotherapy, and poor prognosis, thus makes …

Fyn kinase in brain diseases and cancer: the search for inhibitors

S Schenone, C Brullo, F Musumeci… - Current medicinal …, 2011 - ingentaconnect.com
Fyn is a non-receptor tyrosine kinase belonging to the Src family kinases. It has been shown
to play important roles in neuronal functions, including myelination and oligodendrocytes …

[HTML][HTML] miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer

F Wei, Y Liu, Y Guo, A Xiang, G Wang, X Xue, Z Lu - Molecular cancer, 2013 - Springer
Background Radiation exerts direct antitumor effects and is widely used in clinics, but the
efficacy is severely compromised by tumor resistance. Therefore uncovering the mechanism …

The Long non-coding RNA AC006329. 1 facilitates hepatocellular carcinoma progression and metastasis by regulating miR-127-5p/SHC3/ERK Axis

XX Kong, X Yang, WJ Jiang, DM Zhu… - Journal of …, 2023 - Taylor & Francis
Purpose Hepatocellular carcinoma (HCC) is the most common type of liver cancer and the
sixth largest common cancer worldwide. Although surgical resection, hepatic arterial …